Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

48 results about "Wellness state" patented technology

System and method for providing closely-followed cardiac therapy management through automated patient care

A system and method for providing closely-followed cardiac therapy management through automated patient care is presented. A patient under remote care is enrolled in a monitoring program following commencement of a cardiac therapy regimen to be undertaken by the patient. A wearable monitor, including one or more patient physiology sensors and a wireless interface providing enabling bi-directional data exchange, is provided to the patient. Patient physiometry, including quantitative physiological measures, is periodically collected from the wearable monitor over the wireless interface concomitant to performance of the cardiac therapy regimen. The patient physiometry is evaluated to determine a trend indicating an onset, progression, regression, absence of, and status quo of patient health status.
Owner:CARDIAC PACEMAKERS INC

Magneto-cymatic therapeutic mattress pad

A mattress pad that delivers magnetic and cymatic therapy to a resting or sleeping human body. The device consists of a mattress pad composed of various comfort supporting materials incorporating interspersed throughout the pad small transducers to deliver cymatic vibrations and permanent magnets fixed at the center of each transducer to deliver magnetic field therapy. Both the cymatic vibrations and the magnetic field therapy are delivered to the limbs and organs of the body concurrently. The magnetic field also serves as a conduit for the cymatic vibrations providing a magnetic inductive coupling within the cells of the body which assists in restoring the cells to their healthy-state natural resonant frequency.
Owner:TAB LICENSING

Wearable mini-size intelligent healthcare system

A system and method for the wearable mini-size intelligent healthcare system, comprising one or multiple vital signal sensors, activity sensors, a real-time detection and analyzing module for continuous health monitoring, adjustable user setting mode with the adaptive optimization, data-collecting capability to record important health information, smart audio outputs beep and speech advice to the user through audio path and audio interface, preset and user confirmable alarm conditions via wireless communications network to the appropriate individual for prompt and necessary assistance. The system uses non-invasive monitoring technology for continuous, painless and bloodless health state monitoring. The system also works through the short range RF link with carry-on PDA or cell phone for displaying health information, making urgent contact to support center, doctor or individual, or for information transmission with a healthcare center.
Owner:LUO HONGYUE

Differential expression of nucleic acid molecules

InactiveUS20060228775A1Treatment effectPeptide/protein ingredientsTissue cultureMyopathyMesenteric adipose tissue
The present invention relates generally to nucleic acid molecules expressed at least in the hypothalamus, liver, mesenteric adipose tissue, or red gastrocnemius muscle conveniently identified using differential display techniques under differing physiological conditions. The nucleic acid molecules are associated with or act as markers for conditions of inter alia a healthy state, myopathy, obesity, anorexia, weight maintenance, diabetes, disorders associated with mitochondrial dysfunction, genetic disorders and/or metabolic energy levels. More particularly, the present invention is directed to a nucleic acid molecule and/or its expression product for use in therapeutic and diagnostic protocols for conditions such as inter alia a myopathy, obesity, anorexia, weight maintenance, diabetes, disorders associated with mitochondrial dysfunction, genetic disorders and/or metabolic energy levels. The subject nucleic acid molecule and expression product and their derivatives, homologs, analogs and mimetics are proposed to be useful, therefore, as therapeutic and diagnostic agents for inter alia a myopathy, obesity, anorexia, weight maintenance, diabetes, disorders associated with mitochondrial dysfunction, genetic disorders and/or metabolic energy levels or as targets for the design and/or identification of modulators of their activity and/or function.
Owner:CHEMGENEX PHARMA

System and method for performing a cost-utility analysis of pharmaceutical interventions

InactiveUS20070179809A1To offer comfortMaximize effective useTherapiesFinanceMedicineUtility analysis
A system and a method for performing a cost-utility analysis of pharmaceutical interventions where each pharmaceutical intervention is associated with several potential health states. The system includes a processor and a database. The database contains for each pharmaceutical intervention several utility values associated with each health state and a probability for each potential health state associated with each pharmaceutical intervention. The processor is in communication with the database and determines a mean utility value for each pharmaceutical intervention by correlating each probability associated with each pharmaceutical intervention with the utility value associated with the respective health state. The processor also compares the pharmaceutical interventions the mean utility values of the pharmaceutical interventions by decision analysis.
Owner:BROWN MELISSA M +2

Monitoring System

The present invention is a system for monitoring a health state of a subject. The system is provided with: a measuring unit that chronologically measures the position of the subject in a facility in which the subject resides or stays; and an information processing unit that determines a health state of the subject by determining whether a chronological change in the position of the subject satisfies a predetermined determination condition.
Owner:HITACHI LTD

Health management and monitoring with and without weight loss

Health management and monitoring predicated on an intermittent calorie restricted health management paradigm is provided. In an illustrative implementation, an intermittent calorie restricted health management program is provided to a participating health management subject so improve the health state of the participating subject (e.g., impact disease states in the health management subject) with or without the participating subject observing weight loss. In the context of health monitoring, in an illustrative operation, the levels of the SIRT-1 protein are measured on the participating health management subject. The measured SIRT-1 protein levels provide an indication of whether the participating health management subject is adhering to the provided intermittent calorie restricted health management paradigm.
Owner:JOHNSON JAMES B

Systems and methods for patient monitoring

The present invention discloses systems and methods for monitoring patients with a chronic disease such as heart failure. The system may include a physiological sensor circuit to sense physiological signals and generate signal metrics from the physiological signals. The system may include a health status analyzer circuit to use the signal metrics to generate one or more stability indicators of patient health status, such as stability of heart failure status. The system may additionally generate one or more health status indicators indicating patient health status such as heart failure progression. A patient disposition decision may be generated using the health status indicators and the stability indicators to provide an indication of readiness for patient discharge from or a risk of admission to a hospital.
Owner:CARDIAC PACEMAKERS INC

Application (APP)-based intelligent pet tortoise raising system design method

InactiveCN107751103ARemote control of health statusRemote control of living environment statusHealth-index calculationDrug and medicationsSystems designThe Internet
The invention discloses an application (APP)-based intelligent pet tortoise maintenance system design method. An intelligent raising box is internally provided with a video sensor module, a temperature sensor module and a CO2 concentrating monitoring module, wherein the video sensor module is used for shooting feature information of a pet tortoise and sending the information to a cloud big data analysis system; the cloud big data analysis system is provided with a pet tortoise database, and sample information of the pet tortoise is compared with the massive data in the database by using an intelligent lookup and comparison method, so that the health condition and the types and degrees of diseases of the pet tortoise are obtained; according to the type, age, weight, body length and positioninformation of the pet tortoise, a disease treatment plan and raising advices are given and sent to an APP of a mobile terminal of a user; the user can look over the health condition and living environment of the pet tortoise through the internet by means of the APP of the mobile terminal. After the design method provided by the invention is adopted, the user can look over the health condition and living environment of the pet tortoise from a long distance, so that the ability of the user to raise and supervise the pet tortoise is improved.
Owner:杭州宠舍科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products